Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients

Identifieur interne : 003414 ( PascalFrancis/Corpus ); précédent : 003413; suivant : 003415

Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients

Auteurs : P. E. Greene ; S. Fahn

Source :

RBID : Pascal:96-0177085

Descripteurs français

English descriptors


Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 11
A06       @2 2
A08 01  1  ENG  @1 Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
A11 01  1    @1 GREENE (P. E.)
A11 02  1    @1 FAHN (S.)
A14 01      @1 Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center @2 New York, New York @3 USA @Z 1 aut. @Z 2 aut.
A20       @1 181-184
A21       @1 1996
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000053271850100
A44       @0 0000
A45       @0 9 ref.
A47 01  1    @0 96-0177085
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C02 01  X    @0 002B02C
C03 01  X  FRE  @0 Dystonie @5 01
C03 01  X  ENG  @0 Dystonia @5 01
C03 01  X  SPA  @0 Distonía @5 01
C03 02  X  FRE  @0 Toxine @5 04
C03 02  X  ENG  @0 Toxin @5 04
C03 02  X  SPA  @0 Toxina @5 04
C03 03  X  FRE  @0 Clostridium botulinum @2 NS @5 05
C03 03  X  ENG  @0 Clostridium botulinum @2 NS @5 05
C03 03  X  SPA  @0 Clostridium botulinum @2 NS @5 05
C03 04  X  FRE  @0 Chimiothérapie @5 16
C03 04  X  ENG  @0 Chemotherapy @5 16
C03 04  X  SPA  @0 Quimioterapia @5 16
C03 05  X  FRE  @0 Traitement @5 17
C03 05  X  ENG  @0 Treatment @5 17
C03 05  X  GER  @0 Aufbereiten @5 17
C03 05  X  SPA  @0 Tratamiento @5 17
C03 06  X  FRE  @0 Homme @5 20
C03 06  X  ENG  @0 Human @5 20
C03 06  X  SPA  @0 Hombre @5 20
C03 07  X  FRE  @0 Résistance traitement @5 23
C03 07  X  ENG  @0 Negative therapeutic reaction @5 23
C03 07  X  SPA  @0 Resistencia al tratamiento terapeútico @5 23
C07 01  X  FRE  @0 Clostridiaceae @2 NS
C07 01  X  ENG  @0 Clostridiaceae @2 NS
C07 01  X  SPA  @0 Clostridiaceae @2 NS
C07 02  X  FRE  @0 Clostridiales @2 NS
C07 02  X  ENG  @0 Clostridiales @2 NS
C07 02  X  SPA  @0 Clostridiales @2 NS
C07 03  X  FRE  @0 Bactérie
C07 03  X  ENG  @0 Bacteria
C07 03  X  SPA  @0 Bacteria
C07 04  X  FRE  @0 Muscle strié pathologie @5 37
C07 04  X  ENG  @0 Striated muscle disease @5 37
C07 04  X  SPA  @0 Músculo estriado patología @5 37
C07 05  X  FRE  @0 Système nerveux pathologie @5 38
C07 05  X  ENG  @0 Nervous system diseases @5 38
C07 05  X  SPA  @0 Sistema nervioso patología @5 38
C07 06  X  FRE  @0 Trouble neurologique @5 39
C07 06  X  ENG  @0 Neurological disorder @5 39
C07 06  X  SPA  @0 Trastorno neurológico @5 39
C07 07  X  FRE  @0 Mouvement involontaire @5 40
C07 07  X  ENG  @0 Involuntary movement @5 40
C07 07  X  SPA  @0 Movimiento involuntario @5 40
C07 08  X  FRE  @0 Extrapyramidal syndrome @5 41
C07 08  X  ENG  @0 Extrapyramidal syndrome @5 41
C07 08  X  SPA  @0 Extrapiramidal síndrome @5 41
N21       @1 113

Format Inist (serveur)

NO : PASCAL 96-0177085 INIST
ET : Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
AU : GREENE (P. E.); FAHN (S.)
AF : Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center/New York, New York/Etats-Unis (1 aut., 2 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 2; Pp. 181-184; Bibl. 9 ref.
LA : Anglais
CC : 002B02C
FD : Dystonie; Toxine; Clostridium botulinum; Chimiothérapie; Traitement; Homme; Résistance traitement
FG : Clostridiaceae; Clostridiales; Bactérie; Muscle strié pathologie; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome
ED : Dystonia; Toxin; Clostridium botulinum; Chemotherapy; Treatment; Human; Negative therapeutic reaction
EG : Clostridiaceae; Clostridiales; Bacteria; Striated muscle disease; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome
GD : Aufbereiten
SD : Distonía; Toxina; Clostridium botulinum; Quimioterapia; Tratamiento; Hombre; Resistencia al tratamiento terapeútico
LO : INIST-20953.354000053271850100
ID : 96-0177085

Links to Exploration step

Pascal:96-0177085

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients</title>
<author>
<name sortKey="Greene, P E" sort="Greene, P E" uniqKey="Greene P" first="P. E." last="Greene">P. E. Greene</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Fahn, S" sort="Fahn, S" uniqKey="Fahn S" first="S." last="Fahn">S. Fahn</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">96-0177085</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 96-0177085 INIST</idno>
<idno type="RBID">Pascal:96-0177085</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003414</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients</title>
<author>
<name sortKey="Greene, P E" sort="Greene, P E" uniqKey="Greene P" first="P. E." last="Greene">P. E. Greene</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Fahn, S" sort="Fahn, S" uniqKey="Fahn S" first="S." last="Fahn">S. Fahn</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Chemotherapy</term>
<term>Clostridium botulinum</term>
<term>Dystonia</term>
<term>Human</term>
<term>Negative therapeutic reaction</term>
<term>Toxin</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Dystonie</term>
<term>Toxine</term>
<term>Clostridium botulinum</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Homme</term>
<term>Résistance traitement</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>11</s2>
</fA05>
<fA06>
<s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>GREENE (P. E.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>FAHN (S.)</s1>
</fA11>
<fA14 i1="01">
<s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>181-184</s1>
</fA20>
<fA21>
<s1>1996</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000053271850100</s5>
</fA43>
<fA44>
<s0>0000</s0>
</fA44>
<fA45>
<s0>9 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>96-0177085</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B02C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Toxine</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Toxin</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Toxina</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Chimiothérapie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Chemotherapy</s0>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Quimioterapia</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="GER">
<s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Résistance traitement</s0>
<s5>23</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Negative therapeutic reaction</s0>
<s5>23</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Resistencia al tratamiento terapeútico</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Bactérie</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Bacteria</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Bacteria</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Muscle strié pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Striated muscle disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Músculo estriado patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Mouvement involontaire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Involuntary movement</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Movimiento involuntario</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>113</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 96-0177085 INIST</NO>
<ET>Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients</ET>
<AU>GREENE (P. E.); FAHN (S.)</AU>
<AF>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center/New York, New York/Etats-Unis (1 aut., 2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 2; Pp. 181-184; Bibl. 9 ref.</SO>
<LA>Anglais</LA>
<CC>002B02C</CC>
<FD>Dystonie; Toxine; Clostridium botulinum; Chimiothérapie; Traitement; Homme; Résistance traitement</FD>
<FG>Clostridiaceae; Clostridiales; Bactérie; Muscle strié pathologie; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome</FG>
<ED>Dystonia; Toxin; Clostridium botulinum; Chemotherapy; Treatment; Human; Negative therapeutic reaction</ED>
<EG>Clostridiaceae; Clostridiales; Bacteria; Striated muscle disease; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome</EG>
<GD>Aufbereiten</GD>
<SD>Distonía; Toxina; Clostridium botulinum; Quimioterapia; Tratamiento; Hombre; Resistencia al tratamiento terapeútico</SD>
<LO>INIST-20953.354000053271850100</LO>
<ID>96-0177085</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003414 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003414 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:96-0177085
   |texte=   Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024